Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

被引：0
|
作者：
Laurent Kodjikian
Lluís Arias Barquet
András Papp
Peter J. Kertes
Edoardo Midena
Jan Ernest
Rufino Silva
Thomas Schmelter
Tobias Niesen
Sergio Leal
机构：
[1] Croix-Rousse Teaching Hospital,Department of Ophthalmology
[2] Hospices Civils de Lyon,UMR
[3] Université Claude Bernard Lyon 1,CNRS 5510 Matéis, Villeurbanne
[4] University of Lyon,Department of Ophthalmology
[5] Hospital Universitario de Bellvitge,Department of Ophthalmology
[6] University of Barcelona,Department of Ophthalmology
[7] Semmelweis University,Department of Ophthalmology and Vision Sciences
[8] The John and Liz Tory Eye Centre,Department of Ophthalmology
[9] Sunnybrook Health Sciences Centre,Coimbra Institute for Clinical and Biomedical Research Faculty of Medicine (iCBR
[10] University of Toronto,FMUC)
[11] University Hospital,Ophthalmology Department
[12] Axon Clinical Research Center,undefined
[13] University of Coimbra,undefined
[14] Centro Hospitalar e Universitário de Coimbra (CHUC),undefined
[15] Association for Innovation and Biomedical Research on Light and Image (AIBILI),undefined
[16] Clinical Academic Center of Coimbra (CACC),undefined
[17] Bayer AG,undefined
[18] Bayer Consumer Care AG,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Anatomic outcomes; Anti-vascular endothelial growth factor; Fixed dosing; Functional outcomes; Intravitreal aflibercept; Neovascular age-related macular degeneration; Treat-and-extend; Treatment burden; Treatment interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1010 / 1024
页数：14
相关论文
共 50 条
  • [1] Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing
    Kodjikian, Laurent
    Arias Barquet, Lluis
    Papp, Andras
    Kertes, Peter J.
    Midena, Edoardo
    Ernest, Jan
    Silva, Rufino
    Schmelter, Thomas
    Niesen, Tobias
    Leal, Sergio
    ADVANCES IN THERAPY, 2024, 41 (03) : 1010 - 1024
  • [2] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [3] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Mohamed Kamel Soliman
    Nicolas Tuli
    Thomas K. Lee
    William A. Britton
    Raman Tuli
    International Journal of Retina and Vitreous, 7
  • [4] A Randomized, Controlled Trial of Treat-and-Extend vs. Pro Re Nata Regimen for Neovascular Age-Related Macular Degeneration
    Jia, Huixun
    Lu, Bing
    Yuan, Yuanzhi
    Yuan, Fei
    Li, Lei
    Song, Yanping
    Rong, Ao
    Zhou, Minwen
    Wang, Fenghua
    Sun, Xiaodong
    FRONTIERS IN MEDICINE, 2022, 9
  • [5] Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration
    Soliman, Mohamed Kamel
    Tuli, Nicolas
    Lee, Thomas K.
    Britton, William A.
    Tuli, Raman
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [6] EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION The ARIES Study: A Randomized Clinical Trial
    Mitchell, Paul
    Holz, Frank G.
    Hykin, Philip
    Midena, Edoardo
    Souied, Eric
    Allmeier, Helmut
    Lambrou, George
    Schmelter, Thomas
    Wolf, Sebastian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (09): : 1911 - 1920
  • [7] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 182 : 204 - 205
  • [8] Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial
    Decroos, Francis Char
    Reed, David
    Adam, Murtaza K.
    Salz, David
    Gupta, Omesh P.
    Ho, Allen C.
    Regillo, Carl D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 180 : 142 - 150
  • [9] Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
    Alaa Din Abdin
    Asem Mohamed
    Cristian Munteanu
    Isabel Weinstein
    Achim Langenbucher
    Berthold Seitz
    Shady Suffo
    International Journal of Retina and Vitreous, 7
  • [10] Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
    Abdin, Alaa Din
    Mohamed, Asem
    Munteanu, Cristian
    Weinstein, Isabel
    Langenbucher, Achim
    Seitz, Berthold
    Suffo, Shady
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
12345